Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes by Jojima, Teruo, Kurai, Hidetaka, Tanuma, Dai, Kajitani, Hayato, Kase, Masato, Inoue, Yuiko, Sakurai, Shintaro, Iijima, Toshie, Tomaru, Takuya, Usui, Isao, Aso, Yoshimasa

Get full text

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors by Shibasaki, Ikuko, Nakajima, Toshiaki, Fukuda, Taira, Hasegawa, Takaaki, Ogawa, Hironaga, Tsuchiya, Go, Takei, Yusuke, Tezuka, Masahiro, Kato, Takashi, Kanazawa, Yuta, Kano, Yasuyuki, Kuwata, Toshiyuki, Ouchi, Motoshi, Toyoda, Shigeru, Aso, Yoshimasa, Fukuda, Hirotsugu

Get full text

Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report by Kunii, Tomohisa, Iijima, Toshie, Jojima, Teruo, Shimizu, Masanori, Kase, Masato, Sakurai, Shintaro, Kogai, Takahiko, Usui, Isao, Aso, Yoshimasa

Get full text

Concurrent variant type 3 autoimmune polyglandular syndrome and pulmonary arterial hypertension in a Japanese woman by Toshie Iijima, Takafumi Niitani, Seiichi Tanaka, Kazunori Yanagi, Teruo Jojima, Kunihiro Suzuki, Isao Usui, Yoshimasa Aso

Get full text

Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index by Aoki, Chie, Suzuki, Kunihiro, Kuroda, Hisamoto, Sagara, Masaaki, Shimizu, Masanori, Kasai, Kikuo, Aso, Yoshimasa

Get full text

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication by Shinohara, Yasutake, Iijima, Toshie, Sakurai, Shintaro, Jojima, Teruo, Ohira, Eriko, Hayashi, Shujiro, Usui, Isao, Igawa, Ken, Aso, Yoshimasa

Get full text

A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation by Kishi, Haruka, Jojima, Teruo, Kogai, Takahiko, Iijima, Toshie, Ohira, Eriko, Tanuma, Dai, Konno, Sachiyo, Kato, Kanako, Kezuka, Atsumi, Akimoto, Kazumi, Sakumoto, Junko, Hishinuma, Akira, Tomaru, Takuya, Makita, Noriko, Usui, Isao, Aso, Yoshimasa

Get full text

Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diab... by Shimizu, Masanori, Suzuki, Kunihiro, Kato, Kanako, Jojima, Teruo, Iijima, Toshie, Murohisa, Toshimitsu, Iijima, Makoto, Takekawa, Hidehiro, Usui, Isao, Hiraishi, Hideyuki, Aso, Yoshimasa

Get full text

Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease : longitudinal changes in the numbe... by Toshie Iijima, Teruo Jojima, Soichiro Hosonuma, Eriko Ohhira, Takuya Tomaru, Takahiko Kogai, Isao Usui, Yoshimasa Aso

Get full text

The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expres... by Jojima, Teruo, Wakamatsu, Sho, Kase, Masato, Iijima, Toshie, Maejima, Yuko, Shimomura, Kenju, Kogai, Takahiko, Tomaru, Takuya, Usui, Isao, Aso, Yoshimasa

Get full text

Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis a... by Jojima, Teruo, Tomotsune, Takanori, Iijima, Toshie, Akimoto, Kazumi, Suzuki, Kunihiro, Aso, Yoshimasa

Get full text

Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes by Naruse, Rika, Takebayashi, Kohzo, Morita, Kimio, Aso, Yoshimasa, Inukai, Toshihiko

Get full text

No Negative Impact of a National State of Emergency by COVID-19 Outbreak on Hemoglobin A1c Levels in Patients With Type 2 Diabetes Living in Semi-Rural Japan by Aso, Yoshimasa, Iijima, Toshie, Tomaru, Takuya, Jojima, Teruo, Usui, Isao

Get full text

Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients by Takebayashi, Kohzo, Matsumoto, Sachiko, Aso, Yoshimasa, Inukai, Toshihiko

Get full text

Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis by Sakurai, Shintaro, Jojima, Teruo, Iijima, Toshie, Tomaru, Takuya, Usui, Isao, Aso, Yoshimasa

Get full text

Author reply by Aso, Yoshimasa

Get full text

Miglitol, an Anti-diabetic Drug, Inhibits Oxidative Stress^|^ndash;Induced Apoptosis and Mitochondrial ROS Over-Production in Endothelial Cells by Enhancement of AMP-Activated Prot... by Aoki, Chie, Suzuki, Kunihiro, Yanagi, Kazunori, Satoh, Hiroko, Niitani, Mai, Aso, Yoshimasa

Get full text

Liraglutide increases 24-h heart rate by reducing the cardiac parasympathetic activity of patients with type 2 diabetes: power spectral analysis of heart rate variability on 24-h H... by Hara, Kenji, Aso, Yoshimasa, Komatsu, Takaaki, Nakamachi, Takafumi, Sakai, Yoshihiko, Takayanagi, Kan, Kasai, Kikuo, Inukai, Toshihiko

Get full text

Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipop... by Jojima, Teruo, Sakurai, Shintaro, Wakamatsu, Sho, Iijima, Toshie, Saito, Masahiro, Tomaru, Takuya, Kogai, Takahiko, Usui, Isao, Aso, Yoshimasa

Get full text

Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomi... by Akiyama, Yoshitaka, Morita-Ohkubo, Tomoko, Oshitani, Natsuko, Ohno, Yuko, Aso, Yoshimasa, Inukai, Toshihiko, Kakei, Masafumi, Kawakami, Masanobu, Awata, Takuya, Katayama, Shigehiro, Matsuda, Masafumi

Get full text